Di Nolfo, Maria Anna

Publishing since 2004 (Junior)

Has published 11 publications in 7 years

Number of publications published per year by Di Nolfo, Maria Anna. (Source : PubMed)

Distribution of publications types for Di Nolfo, Maria Anna. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Mirici-Cappa F, Gramenzi A, Santi V, Zambruni A, Di Micoli A, Frigerio M, Maraldi F, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M, Trevisani F. Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience.  Gut  2010;59;3  
•  Giannini EG, Bodini G, Corbo M, Savarino V, Risso D, Di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F. Impact of evidence-based medicine on the treatment of patients with unresectable hepatocellular carcinoma.  Aliment. Pharmacol. Ther.  2010;31;4  
•  Farinati F, Sergio A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F. Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?  Eur J Gastroenterol Hepatol  2009;21;10  
•  Giannini EG, Marabotto E, Savarino V, Trevisani F, di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M. Hepatocellular carcinoma in patients with cryptogenic cirrhosis.  Clin. Gastroenterol. Hepatol.  2009;7;5  
•  Giannini EG, Marabotto E, Savarino V, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Farinati F, Zoli M, Borzio F, Caturelli E, Chiaramonte M. Hepatocellular carcinoma in patients with cryptogenic cirrhosis.  Clin. Gastroenterol. Hepatol.  2009  
•  Farinati F, Sergio A, Baldan A, Giacomin A, Di Nolfo MA, Del Poggio P, Benvegnu L, Rapaccini G, Zoli M, Borzio F, Giannini EG, Caturelli E, Trevisani F. Early and very early hepatocellular carcinoma: when and how much do staging and choice of treatment really matter? A multi-center study.  BMC Cancer  2009;9  
•  Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?  Am. J. Gastroenterol.  2007;102;11  
•  Trevisani F, Magini G, Santi V, Morselli-Labate AM, Cantarini MC, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.  Am. J. Gastroenterol.  2007;102;5  
•  Giannini EG, Risso D, Testa R, Trevisani F, Di Nolfo MA, Del Poggio P, Benvegnù L, Ludovico Rapaccini G, Farinati F, Zoli M, Borzio F, Caturelli E. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma.  Clin. Gastroenterol. Hepatol.  2006;4;11  
•  Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C, Rapaccini G, Del Poggio P, Di Nolfo MA, Benvegnù L, Zoli M, Borzio F, Bernardi M, Trevisani F. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?  Am. J. Gastroenterol.  2006;101;3  

[ See timeline ] [ See all publications ]